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Crowd WisdomY. Chandrashekhar, MD,* Jagat Narula, MD, PHDyT he landscape of scientiﬁc publishing ischanging rapidly, as are the challenges facedby journal editors. While estimates are
imprecise, approximately 8.5 million science, tech-
nical, and medicine (STM) researchers published
more than 1.8 million articles in almost 22,000 peer-
reviewed journals in the year 2012 (1). The total
corpus of published knowledge is more than 50
million papers (2). Older studies had predicted a 3%
yearly growth, doubling over a 24-year period (3),
but medical publications actually may have been
growing faster than predicted—at a 5.6% annual
growth rate, doubling over a 13-year period. The
explosion of newer ways of creating and sharing con-
tent online will continue to accelerate this pattern.
The volume of research data available is projected
to grow from 0.8 trillion gigabytes to more than
35 trillion gigabytes in a decade (4). What are the
new challenges to authors, reviewers, editors, and
readers in the new landscape?
ROLE OF A JOURNAL: EYE OF THE BEHOLDER
Society wants published science to advance man-
kind with believable progress. Medical journals are
responsible for maintaining relevant content and
moving science forward in a meaningful way. Readers
are interested in staying informed, keeping up with
the torrent of information, and ﬁnding their “go-to”
source. The younger generation of readers, growing
up in the digital age, may ask even more pointed
questions, including: should editors decide what is
presented to them, or should consumers be accessingVA Medical
edicine atunvetted content freely and decide on their own?
This new wave of thinking might eventually creep
into medicine as well. The ultimate “Holy Grail” for
the reader is the ability to seamlessly access and
personalize published information, and maybe even
to create content they can store or share.
RESEARCH AND QUEST FOR TRUTH:
IS SCIENCE A SISYPHEAN TASK?
Editors are faced with major hurdles in the quest
for publishing perfectly believable and translatable,
yet impactful, content. Science deals with uncertainty
and pure scientiﬁc truth is like the speed of light—
something we can move toward but never reach.
Ionnadis et al. have concluded that very many papers
are likely to bewrong due to a variety of inherent issues
(5) and even randomized controlled trials might
be disproven or their impact minimized with subse-
quent investigation (6). Many studies might not
be repeatable, and conclusions change over time,
such as cholesterol guidelines, or hormone replace-
ment therapy in women. Most highly regarded papers
do their best to provide a practical truth that might
be usable with maximum beneﬁt and minimal detri-
ment, rather than an absolute truth. This delicate
balance is difﬁcult to understand and can inﬂuence
societal support for the scientiﬁc method.
PERFECTION IN AN IMPERFECT WORLD
Given the imperfections in research, what can make
science believable to stakeholders? Publication of
high-quality papers is the obvious answer. This is a
big hurdle, since there is no good universal metric
for quality. A working paradigm could be to publish
“novelty that moves the ﬁeld forward.” Often the
ﬂawed metric of impact factor seems to creep into
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623decision-making. Publishing in a high impact factor
journal does signify a higher quality paper, but such
journals also have a higher number of retractions (7).
The review process is an attempt to ensure that
the data are robust, unbiased, and obtained with a
rigorous, repeatable methodology but cannot assure
that the data are true. Can editors arbitrate between
believable and unbelievable science? Should they
withhold science they do not believe, especially when
the “unbelievable part” might have the potential to
be the groundbreaking science? Editors sometimes
have a nagging feeling that our preconceived notions
might cloud our judgment. Time and again, unbe-
lievable data have turned out to be very important.
The early papers on vasodilator therapy or the use
of beta-blockers in heart failure provide some exam-
ples. Editorial boards face a daunting task to dis-
tinguish among the inaccuracies that arise from
negligence, and academic sloppiness, to outright in-
tentional fraud, and to the revolutionary novelty of
data. Editorial misjudgments about where a contro-
versial paper fall in this spectrum can have signiﬁcant
consequences, and most editors tread carefully in
this realm. Their decisions might affect public accep-
tance of science and patient compliance and could
erode the support for science. It is evolving into a
major issue (8) and seemingly increased reporting of
academic malpractice and journal retractions make
this a mineﬁeld for editors.
HOW COMMON IS MALPRACTICE
IN MEDICAL RESEARCH?
Media headlines make it seem like medical journals
are rife with unhealthy science (9,10). However, is
scientiﬁc research fraud really on the rise or are the
reported ones the most egregious (10)? It appears that
while retractions are on the rise (11), the most
exhaustive study in this area found that misconduct
was seen in 1 in 10,000 papers. Of these, only 25%
were due to error and the rest due to fraud of varying
degrees (7). It might also just be a case of discovering
fraud more easily under greater scrutiny and auto-
matic digital sleuthing (e.g., CrossCheck). However,
some feel that the fraudulent reporting is under-
estimated (12). Of the many possible avenues
of falsehood in manuscripts submitted for publica-
tion, some are easier to detect (e.g., the plagiarism)
than others (fabrication or falsiﬁcation). Plagiarism-
detecting software or image-matching software (11)
or even crowd wisdom on social media (13) can help,
but the editors have to rely on experience, depth of
expertise of the board members, and most impor-
tantly, eagle-eyed peer reviewers.IS SCIENCE BASED ON “TRUST” THE CULPRIT?
DO WE NEED A SARBANES-OXLEY ACT?
The current paradigm of science—where editors re-
view papers on face value and honesty is assumed—
allows unwanted elasticity in ethical publishing.
However, we do not foresee any other system that
may replace this process. Quite similar to Churchill’s
quote on democracy it may be the best of all imper-
fect systems, since, editors cannot police research
data all of the time. We strongly feel that nipping bad
data at source is more effective than catching it at the
Journal stage and feel that this kind of supervision
should be primarily left to universities and research
facilities. We are also cautiously intrigued by the
idea of having someone other than the investigator
oversee/certify the veracity of the process at its
source before submission for publication; this could
even become a “just in time” step, after the paper is
accepted. This may better ensure that the research
submitted conformed to current standards, a situa-
tion akin to good laboratory practice (GLP) studies.
We also realize the pitfalls. It may not be possible
for administrators to detect subtle dishonesty, and
might impose a burden on investigators. Regardless,
something must be done to restore conﬁdence in the
entire research enterprise. A similar requirement ex-
ists in the ﬁnancial world, the Sarbanes-Oxley Act.
There is an ongoing debate whether the scrutiny
of the reporting company has resulted in enhanced
honesty. This experience should guide us while con-
sidering such an option in research. However, the
implications of dishonest research in medicine are
signiﬁcantly more devastating than a company mis-
reporting its ﬁnancial performance; whereas there
are civil and criminal remedies for those affected by
ﬁnancial misconduct, nearly none exist for victims of
biomedical research. There needs to be serious dis-
cussions about certifying veracity of the effort and
determine who in addition to the vested investigator,
should be involved to ensure the apt reporting of
science at the source.
DO CHANGES IN THE PUBLISHING
LANDSCAPE ENCOURAGE LOOSE SCIENCE?
Journals, in the traditional sense, are meant to
foster scholarly communication while ensuring
some form of “quality” via robust, expert peer re-
view. At the same time, STM publishing is also a big
business (1). It is estimated that English STM jour-
nals generated $9.4 billion in 2011, and the entire
market was worth $23.5 billion. This has naturally
attracted a number of less reliable players. There
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624were approximately 8,115 open-access journals in
2012, and this number is said to be growing at the
rate of 3.5 new journals every day. Only a small
proportion of these are fully peer-reviewed in the
traditional sense, leading to abuses like pay to play
(14), ghost writing (15) or selling authorship (16).
Because aggregated sources including repositories
may not be able to discern quality and process
differences among Journals, these kinds of publi-
cations are more likely to destroy veracity in the
scientiﬁc research process than premeditated fraud
in peer-reviewed journals.
DOES THIS NEED A SYSTEMIC SOLUTION?
Within the democratic scientiﬁc enterprise, science
will, at least in the foreseeable future, remain an
endeavor of trust. However, we need to upgrade this
to “trust, but verify”. A number of suggestions have
been made on how to enhance conﬁdence among
stakeholders that scientiﬁc papers are indeed useful
and accurate (17). One recommendation is increased
training for investigators (18), which has been met
with mixed results (19) A harmonization of good
research practices training internationally might be
of help. In the end, we are left with self-correcting
mechanisms like more thorough peer review,
including disclosing comments and/or the reviewers;
post-publication comments/critiques; efforts at rep-
lication of studies; and the wisdom of the readership
to cast sunshine on papers. Mandatory contribution
of data to repositories might enhance widespread
availability—and scrutiny. Data mining software might
reveal less obvious inconsistencies. Future steps
might include provision of raw data for editorial scru-
tiny, periodic audit of the peer-review process, as
well as more comprehensive disclosures. A strong
correspondence section that relaxes the statute of
limitations for debate might be useful. Publishing
negative reports might diminish pressure to slant
experiments to show a positive, publishable result.
Statements from the Committee on Publication Ethics
and the U.K. concordat are trying to highlight the
problem, and suggest solutions.
An alternate route is to address the root causes of
suboptimal science. In the last few decades, the
reward structure of medical research has changed
signiﬁcantly, and pressure to publish and the winner-
takes-all formats have made research an extremely
challenging career. There is greater collaboration with
industry, bringing with it a conﬂict of interest and
pressure to align questions, protocols, and in some
instances, format of publication with those of a non-
independent funding source. Even guidelines, onceconsidered a pure, ﬁltered collective wisdom of ex-
perts, are now looked upon with suspicion (20). With
advent of the Internet and greater emphasis on pub-
lication productivity as a metric for rewards, the
pressure to publish positive studies has created
more relaxed avenues for publication. Correcting
these problems, while important, is a long-term un-
dertaking. The two of us personally believe that the
most urgent change should be to encourage non-
punitive redressing of ﬂawed data. Journals & regula-
tory agencies should create a mechanism to provide
some kind of meaningful immunity for self-disclosure
of scientiﬁc dishonesty, even if done anonymously.
Authors should be allowed to retract data without
stigma if they believe they can no longer vouch for
its veracity. Cleaning up science is so vital that it
should take precedence over punishing perpetrators.
Our personal opinion is that this will help clean up
science more effectively than all possible regulatory
or paperwork solutions.
CONCLUSIONS
Ultimately, clean and honest science vacuums up
inaccurate science. Early ﬁndings have the greatest
uncertainty, and froth; dubious research is discovered
only with the passage of time when the ferment of
science settles down and other eyes and experiments
get to scrutinize it. As Warren Buffett says, “Only
when the tide goes out do you discover who’s been
swimming naked”. One wishes there was a more
expeditious way to discover ﬂawed science rather
than this expensive route in terms of time and wasted
resources, but it is currently the best pathway without
creating a policing milieu and scaring away in-
vestigators altogether from science. Journals play an
important role in preventing dubious research and
in disseminating the truth; demystifying science and
scientiﬁc communication will be more important in
future. Encouraging data sharing, requiring detailed
raw data ﬁles, increasing access via open re-
positories, using best practice guidance, and intro-
ducing GLP-like requirements will help. Stopping
misconduct at its source may be more effective than
at the publication stage. Failure to stem this scourge
will destroy society’s faith in scientiﬁc research and
may shackle science by inviting burdensome, inef-
fective regulations. We need to bend the curve of
imperfect science, and we must do it relatively soon.
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